These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 30572924

  • 1. Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy.
    Mastroianni A, Gaibani P, Rossini G, Vocale C, Re MC, Ravaglia G, Sambri V, Varani S.
    AIDS Res Ther; 2018 Dec 20; 15(1):27. PubMed ID: 30572924
    [Abstract] [Full Text] [Related]

  • 2. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
    Patole S, Burza S, Varghese GM.
    Int J Infect Dis; 2014 Aug 20; 25():204-6. PubMed ID: 24927662
    [Abstract] [Full Text] [Related]

  • 3. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C, Diro E, de Lima Pereira A, Buyze J, Stille K, Ahmed F, van Griensven J, Ritmeijer K.
    PLoS Negl Trop Dis; 2018 May 20; 12(5):e0006527. PubMed ID: 29799869
    [Abstract] [Full Text] [Related]

  • 4. Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.
    van Griensven J, Mengesha B, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Vogt F, Adriaensen W, Diro E.
    Front Cell Infect Microbiol; 2018 May 20; 8():94. PubMed ID: 29651411
    [Abstract] [Full Text] [Related]

  • 5. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF, de Sousa MR, de Mendonça AL, Patrocinio A, Assunção LS, de Faria SR, Rabello A.
    PLoS Negl Trop Dis; 2014 Apr 20; 8(4):e2816. PubMed ID: 24743472
    [Abstract] [Full Text] [Related]

  • 6. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
    Vogt F, Mengesha B, Asmamaw H, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Adriaensen W, Melsew Y, van Griensven J, Diro E.
    Am J Trop Med Hyg; 2018 Oct 20; 99(4):957-966. PubMed ID: 30084342
    [Abstract] [Full Text] [Related]

  • 7. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1702-9. PubMed ID: 18419422
    [Abstract] [Full Text] [Related]

  • 8. Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
    Gow NJ, Davidson RN, Ticehurst R, Burns A, Thomas MG.
    PLoS Negl Trop Dis; 2015 Jun 01; 9(8):e0003983. PubMed ID: 26305562
    [Abstract] [Full Text] [Related]

  • 9. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S, Mahajan R, Sinha PK, van Griensven J, Pandey K, Lima MA, Sanz MG, Sunyoto T, Kumar S, Mitra G, Kumar R, Verma N, Das P.
    PLoS Negl Trop Dis; 2014 Aug 01; 8(8):e3053. PubMed ID: 25101665
    [Abstract] [Full Text] [Related]

  • 10. An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection.
    Elliott T, Simpson J, Naresh KN, Lockwood D, Bailey AC.
    Int J STD AIDS; 2019 Oct 01; 30(12):1221-1223. PubMed ID: 31558131
    [No Abstract] [Full Text] [Related]

  • 11. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP.
    Clin Infect Dis; 2011 Oct 01; 53(7):e91-8. PubMed ID: 21890763
    [Abstract] [Full Text] [Related]

  • 12. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M.
    Clin Infect Dis; 2009 Jan 15; 48(2):e16-22. PubMed ID: 19093811
    [Abstract] [Full Text] [Related]

  • 13. Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?
    Dujardin A, de La Blanchardière A, Dina J, Stefic K, Ravel C, Bonhomme J, Verdon R, Fournier AL.
    Front Immunol; 2021 Jan 15; 12():669723. PubMed ID: 33968076
    [Abstract] [Full Text] [Related]

  • 14. Case Report: Intravenous Pentamidine Rescue Treatment for Active Chronic Visceral Leishmaniasis in an HIV-1 Infected Patient.
    Chechi F, Corsi P, Bartolozzi D, Gaiera G, Bartoloni A, Zammarchi L.
    Am J Trop Med Hyg; 2021 Nov 15; 106(2):639-642. PubMed ID: 34781255
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF, Morquin D, Reynes J, Chirouze C, Hoen B, Le Moing V.
    Parasitol Int; 2016 Oct 15; 65(5 Pt A):444-6. PubMed ID: 27353022
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
    Diro E, Blesson S, Edwards T, Ritmeijer K, Fikre H, Admassu H, Kibret A, Ellis SJ, Bardonneau C, Zijlstra EE, Soipei P, Mutinda B, Omollo R, Kimutai R, Omwalo G, Wasunna M, Tadesse F, Alves F, Strub-Wourgaft N, Hailu A, Alexander N, Alvar J.
    PLoS Negl Trop Dis; 2019 Jan 15; 13(1):e0006988. PubMed ID: 30653490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV viral load and response to antileishmanial chemotherapy in co-infected patients.
    Berhe N, Wolday D, Hailu A, Abraham Y, Ali A, Gebre-Michael T, Desjeux P, Sönnerborg A, Akuffo H, Britton S.
    AIDS; 1999 Oct 01; 13(14):1921-5. PubMed ID: 10513651
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.